Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice [0.03%]
临床实践中的高危患者使用罗苏伐他汀、阿托伐他汀和辛伐他汀的有效性和成本效益分析
Robert L Ohsfeldt,Sanjay K Gandhi,Kathleen M Fox et al.
Robert L Ohsfeldt et al.
Background: Assessments of the effectiveness and cost-effectiveness of treatment with statins in high risk patients in routine clinical practice are needed. The objective of the present study was to estimate the clinical ...
Comparative Study
The American journal of managed care. 2006 Nov;12(15 Suppl):S412-23. DOI: 2006
Differences between clinical trial efficacy and real-world effectiveness [0.03%]
临床试验疗效与现实世界有效性的差异分析
Michael H Davidson
Michael H Davidson
Aggressive lowering of low-density lipoprotein cholesterol (LDL-C) with statin therapy can reduce the incidence of morbidity and mortality from coronary heart disease (CHD) in primary and secondary prevention settings. Indeed, suboptimal st...
Ethnic, gender, and age-related differences in the treatment of dyslipidemia [0.03%]
种族、性别和年龄相关的血脂治疗差异
Keith C Ferdinand
Keith C Ferdinand
Coronary heart disease (CHD) remains the leading cause of mortality in the United States, and factors such as age, gender, or race/ethnicity have a significant impact on cardiovascular risk. More than 80% of people who die from CHD are 65 y...
Case study [0.03%]
案例研究
James R LaSalle,Ashok Balasubramanyam
James R LaSalle
Case Reports
The American journal of managed care. 2006 Nov;12(14 Suppl):S392. DOI: 2006
Ashok Balasubramanyam
Ashok Balasubramanyam
Direct and indirect costs for diabetes mellitus place a large economic burden on the US healthcare system. Diabetes and cardiovascular disease (CVD) are closely interrelated, and it is estimated that much of the burden of CVD too is attribu...
Oral combination therapy with thiazolidinediones in type 2 diabetes [0.03%]
2型糖尿病患者口服胰岛素增敏剂联合治疗的效果及安全性
James R LaSalle,L Brian Cross
James R LaSalle
Insulin resistance occurs early in the type 2 diabetes disease process, leading to progressive beta cell failure and overt diabetes. By the time the diagnosis of diabetes is made, advanced macrovascular disease may already be present. Monot...
Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care [0.03%]
共付水平与抗高血压药的依从性：关于管理式医疗的分析和政策含义
Deborah A Taira,Ken S Wong,Feride Frech-Tamas et al.
Deborah A Taira et al.
Objective: To measure the impact of medication copayment level and other predictors on compliance with antihypertensive medications, as measured by the medication possession ratio. ...